Análise da atuação profissional do farmacêutico em oncologia: uma revisão de literatura / Analysis of the pharmacist's professional performance in oncology: a literature review
DOI:
https://doi.org/10.34117/bjdv8n6-060Keywords:
farmácia, câncer, medicamentos.Abstract
Objetivo: Investigar a importância da atuação profissional do farmacêutico no âmbito da oncologia. Método: Foi realizado um estudo exploratório, a partir de uma pesquisa bibliográfica. O delineamento metodológico abrangeu quatro etapas: (1) Busca de estudos nas bases de dados e livros didáticos; (2) Identificação, seleção e categorização de estudos; (3) Extração de Informações e (4) Análise de dados com leitura analítica. Resultados: A coleta de dados inicial resultou em ∑n = 26 estudos relevantes (24 estudos na modalidade de artigo científico publicado em periódico eletrônico e 2 textos na modalidade de capítulo presente em livro didático da área), após aplicação dos critérios de elegibilidade e concordância em pares dos autores deste manuscrito, resultaram ∑n = 9 estudos para análise final e registro em quadro específico. Conclusão: A atuação do farmacêutico em oncologia está em constante evolução, e seu papel tem sido identificado como vital para o cuidado e sobrevida incremental de pacientes com câncer.
References
Pearson GJ. Evolution in the practice of pharmacy--not a revolution! CMAJ [Internet]. 2007 Apr 24;176(9):1295–6. Available from: https://pubmed.ncbi.nlm.nih.gov/17452664
Merks P, Jakubowska M, Drelich E, Świeczkowski D, Bogusz J, Bilmin K, et al. The legal extension of the role of pharmacists in light of the COVID-19 global pandemic. Res Soc Adm Pharm [Internet]. 2021;17(1):1807–12. Available from: https://www.sciencedirect.com/science/article/pii/S1551741120306628
Rotta I, Salgado TM, Silva ML, Correr CJ, Fernandez-Llimos F. Effectiveness of clinical pharmacy services: an overview of systematic reviews (2000–2010). Int J Clin Pharm [Internet]. 2015;37(5):687–97. Available from: https://doi.org/10.1007/s11096-015-0137-9
Toklu HZ, Hussain A. The changing face of pharmacy practice and the need for a new model of pharmacy education. J Young Pharm [Internet]. 2013/03/30. 2013 Jun;5(2):38–40. Available from: https://pubmed.ncbi.nlm.nih.gov/24023452
Holle LM, Segal EM, Jeffers KD. The Expanding Role of the Oncology Pharmacist. Pharm (Basel, Switzerland) [Internet]. 2020 Jul 25;8(3):130. Available from: https://pubmed.ncbi.nlm.nih.gov/32722357
Segal EM, Bates J, Fleszar SL, Holle LM, Kennerly-Shah J, Rockey M, et al. Demonstrating the value of the oncology pharmacist within the healthcare team. J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract. 2019 Dec;25(8):1945–67.
Muluneh B, Schneider M, Faso A, Amerine L, Daniels R, Crisp B, et al. Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program. J Oncol Pract. 2018 Jun;14(6):e324–34.
Maggio LA, Sewell JL, Artino Jr AR. The Literature Review: A Foundation for High-Quality Medical Education Research. J Grad Med Educ [Internet]. 2016 Jul;8(3):297–303. Available from: https://pubmed.ncbi.nlm.nih.gov/27413425
Waterfield J. Is pharmacy a knowledge-based profession? Am J Pharm Educ [Internet]. 2010 Apr 12;74(3):50. Available from: https://pubmed.ncbi.nlm.nih.gov/20498743
Hohmann NS, McDaniel CC, Mason SW, Cheung WY, Williams MS, Salvador C, et al. Patient perspectives on primary care and oncology care coordination in the context of multiple chronic conditions: A systematic review. Res Soc Adm Pharm [Internet]. 2020;16(8):1003–16. Available from: https://doi.org/10.1016/j.sapharm.2019.11.014
Faguet GB. A brief history of cancer: Age-old milestones underlying our current knowledge database. Int J Cancer [Internet]. 2015 May 1;136(9):2022–36. Available from: https://doi.org/10.1002/ijc.29134
Blackadar CB. Historical review of the causes of cancer. World J Clin Oncol [Internet]. 2016 Feb 10;7(1):54–86. Available from: https://pubmed.ncbi.nlm.nih.gov/26862491
Warren JL, Mariotto AB, Meekins A, Topor M, Brown ML. Current and future utilization of services from medical oncologists. J Clin Oncol. 2008;26(19):3242–7.
Tezcan S, Izzettin FV, Sancar M, Turhal NS, Yumuk PF. Role of clinical oncology pharmacist in determination of pharmaceutical care needs in patients with colorectal cancer. Eur J Hosp Pharm . 2018;25(e1):E17–20.
Gatwood J, Gatwood K, Gabre E, Alexander M. Impact of clinical pharmacists in outpatient oncology practices: A review. Am J Heal Pharm. 2017;74(19):1549–57.
Robertson DLN, Babar ZUD. Pharmaceutical care of patients with cancer treated on non-cancer wards in the UK: A mixed methods study. Eur J Hosp Pharm . 2020;27(3):143–50.
Carrington C, Weir J, Smith P. The development of a competency framework for pharmacists providing cancer services. J Oncol Pharm Pract. 2011;17(3):168–78.
Trovato JA, Thompson A, Duffy AP. Student confidence with oncology pharmacy competencies. Curr Pharm Teach Learn [Internet]. 2019;11(11):1172–7. Available from: https://www.sciencedirect.com/science/article/pii/S1877129719300310
Holle LM, Boehnke Michaud L. Oncology Pharmacists in Health Care Delivery: Vital Members of the Cancer Care Team. J Oncol Pract [Internet]. 2014 Mar 11;10(3):e142–5. Available from: https://doi.org/10.1200/JOP.2013.001257
Ribed A, Romero-Jiménez RM, Escudero-Vilaplana V, Iglesias-Peinado I, Herranz-Alonso A, Codina C, et al. Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction. Int J Clin Pharm. 2016;38(2):280–8.
Umar RM, Apikoglu-Rabus S, Yumuk PF. Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients. Int J Clin Pharm [Internet]. 2020;42(2):652–61. Available from: https://doi.org/10.1007/s11096-020-00992-8
Shawahna R, Awawdeh H. Pharmacists’ knowledge, attitudes, beliefs, and barriers toward breast cancer health promotion: a cross-sectional study in the Palestinian territories. BMC Health Serv Res. 2021;21(1):1–14.
Iihara H, Ishihara M, Matsuura K, Kurahashi S, Takahashi T, Kawaguchi Y, et al. Pharmacists contribute to the improved efficiency of medical practices in the outpatient cancer chemotherapy clinic. J Eval Clin Pract. 2012;18(4):753–60.
Liekweg A, Westfeld M, Braun M, Zivanovic O, Schink T, Kuhn W, et al. Pharmaceutical care for patients with breast and ovarian cancer. Support Care Cancer. 2012;20(11):2669–77.
Wang Y, Wu H, Xu F. Impact of clinical pharmacy services on KAP and QOL in Cancer Patients: A single-center experience. Biomed Res Int. 2015;2015.
Tanaka K, Hori A, Tachi T, Osawa T, Nagaya K, Makino T, et al. Impact of pharmacist counseling on reducing instances of adverse events that can affect the quality of life of chemotherapy outpatients with breast Cancer. J Pharm Heal Care Sci. 2018;4(1):1–14.
